litlas
ログインアカウント作成

Laurence H. Baker

1972–2022 年に発表

75
論文数
19,890
被引用数
71
h 指数
74
i10 指数

被引用数

Laurence H. Baker の年別被引用数1972 年: 被引用 1 件1973 年: 被引用 2 件1974 年: 被引用 10 件1975 年: 被引用 17 件1976 年: 被引用 5 件1977 年: 被引用 10 件1978 年: 被引用 6 件1979 年: 被引用 6 件1980 年: 被引用 12 件1981 年: 被引用 13 件1982 年: 被引用 14 件1983 年: 被引用 24 件1984 年: 被引用 13 件1985 年: 被引用 16 件1986 年: 被引用 5 件1987 年: 被引用 23 件1988 年: 被引用 19 件1989 年: 被引用 10 件1990 年: 被引用 28 件1991 年: 被引用 26 件1992 年: 被引用 28 件1993 年: 被引用 28 件1994 年: 被引用 27 件1995 年: 被引用 28 件1996 年: 被引用 29 件1997 年: 被引用 17 件1998 年: 被引用 25 件1999 年: 被引用 32 件2000 年: 被引用 39 件2001 年: 被引用 42 件2002 年: 被引用 60 件2003 年: 被引用 43 件2004 年: 被引用 48 件2005 年: 被引用 81 件2006 年: 被引用 59 件2007 年: 被引用 61 件2008 年: 被引用 68 件2009 年: 被引用 132 件2010 年: 被引用 140 件2011 年: 被引用 147 件2012 年: 被引用 173 件2013 年: 被引用 202 件2014 年: 被引用 137 件2015 年: 被引用 144 件2016 年: 被引用 164 件2017 年: 被引用 164 件2018 年: 被引用 177 件2019 年: 被引用 504 件2020 年: 被引用 577 件2021 年: 被引用 488 件2022 年: 被引用 372 件2023 年: 被引用 284 件2024 年: 被引用 379 件2025 年: 被引用 153 件2026 年: 被引用 2 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,403 件、この内訳の 31.9%中国: 引用元論文 573 件、この内訳の 7.6%イギリス: 引用元論文 520 件、この内訳の 6.9%イタリア: 引用元論文 438 件、この内訳の 5.8%フランス: 引用元論文 380 件、この内訳の 5%ドイツ: 引用元論文 374 件、この内訳の 5%オランダ: 引用元論文 248 件、この内訳の 3.3%カナダ: 引用元論文 230 件、この内訳の 3%スペイン: 引用元論文 206 件、この内訳の 2.7%日本: 引用元論文 199 件、この内訳の 2.6%オーストラリア: 引用元論文 160 件、この内訳の 2.1%スイス: 引用元論文 125 件、この内訳の 1.7%
0%31.9%その他 22.4%

機関

分野

  • Medicine66.8%
  • Biochemistry, Genetics and Molecular Biology15.2%
  • Nursing7.2%
  • Health Professions2.1%
  • Immunology and Microbiology2.1%
  • Neuroscience1.3%
  • その他5.3%

トピック

  • Sarcoma Diagnosis and Treatment8.1%
  • Selenium in Biological Systems2.3%
  • Vascular Tumors and Angiosarcomas2.1%
  • Cancer Genomics and Diagnostics2%
  • Cancer Immunotherapy and Biomarkers1.8%
  • Cardiac tumors and thrombi1.7%
  • その他82%

共著者

全論文

検索で開く
  1. Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

    著者: Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack, Brian A. Van Tine, Scott M. Schuetze, James Hu, Sandra P. D’Angelo, Steven Attia, Richard F. Riedel, Dennis A. Priebat, Sujana Movva, Lara E. Davis, Scott H. Okuno, Damon R. Reed, John Crowley, Lisa H. Butterfield, Ruth Salazar, Jaime Rodriguez‐Canales, Alexander J. Lazar, Ignacio I. Wistuba, Laurence H. Baker, Robert G. Maki, Denise K. Reinke, Shreyaskumar Patel - The Lancet Oncology 2017 被引用: 1,423

  2. Vitamin E and the Risk of Prostate Cancer

    著者: Eric A. Klein, Ian M. Thompson, Catherine M. Tangen, John J. Crowley, M. Scott Lucia, Phyllis J. Goodman, Lori M. Minasian, Leslie G. Ford, Howard L. Parnes, J. Michael Gaziano, Daniel D. Karp, Michael M. Lieber, Philip Walther, Laurence Klotz, J. Kellogg Parsons, Joseph L. Chin, Amy K. Darke, Scott M. Lippman, Gary E. Goodman, Frank L. Meyskens, Laurence H. Baker - JAMA 2011 被引用: 1,738

  3. Integrative clinical genomics of metastatic cancer

    著者: Dan R. Robinson, Yi-Mi Wu, Robert J. Lonigro, Pankaj Vats, Erin Cobain, Jessica Everett, Xuhong Cao, Erica Rabban, Chandan Kumar-Sinha, Victoria Raymond, Scott Schuetze, Ajjai Alva, Javed Siddiqui, Rashmi Chugh, Francis Worden, Mark M. Zalupski, Jeffrey W. Innis, Rajen J. Mody, Scott A. Tomlins, David Lucas, Laurence H. Baker, Nithya Ramnath, Ann F. Schott, Daniel F. Hayes, Joseph Vijai, Kenneth Offit, Elena M. Stoffel, J. Scott Roberts, David C. Smith, Lakshmi P. Kunju, Moshe Talpaz, Marcin Cieslik, Arul M. Chinnaiyan - Nature, Nat. 2017 被引用: 938

  4. Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers

    著者: Scott M. Lippman, Eric A. Klein, Phyllis J. Goodman, M. Scott Lucia, Ian M. Thompson, Leslie G. Ford, Howard L. Parnes, Lori M. Minasian, J. Michael Gaziano, Jo Ann Hartline, J. Kellogg Parsons, James D. Bearden, E. David Crawford, Gary E. Goodman, Jaime O. Claudio, Eric Winquist, Elise D. Cook, Daniel D. Karp, Philip Walther, Michael M. Lieber, Alan R. Kristal, Amy K. Darke, Kathryn B. Arnold, Peter Ganz, Regina M. Santella, Demetrius Albanes, Philip R. Taylor, Jeffrey L. Probstfield, T. J. Jagpal, John J. Crowley, Frank L. Meyskens, Laurence H. Baker, Charles A. Coltman - JAMA 2008 被引用: 2,115

  5. Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002

    著者: Robert G. Maki, J. Kyle Wathen, Shreyaskumar Patel, Dennis A. Priebat, Scott H. Okuno, Brian L. Samuels, Michael Fanucchi, David C. Harmon, Scott M. Schuetze, Denise K. Reinke, Peter F. Thall, Robert S. Benjamin, Laurence H. Baker, Martee L. Hensley - Journal of Clinical Oncology 2007 被引用: 733

  6. Clinical activity of pembrolizumab (P) in undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated/pleomorphic liposarcoma (LPS): Final results of SARC028 expansion cohorts.

    著者: Melissa Burgess, Vanessa Bolejack, Scott M. Schuetze, Brian Andrew Van Tine, Steven Attia, Richard F. Riedel, James Hu, Lara E. Davis, Scott H. Okuno, Dennis A. Priebat, Sujana Movva, Damon R. Reed, Sandra P. D’Angelo, Alexander J. Lazar, Emily Z. Keung, Denise K. Reinke, Laurence H. Baker, Robert G. Maki, Shreyaskumar Patel, Hussein Tawbi - Journal of Clinical Oncology 2019 被引用: 138

  7. Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules

    著者: George D. Demetri, Sant P. Chawla, Margaret von Mehren, Paul S. Ritch, Laurence H. Baker, Jean‐Yves Blay, Kenneth R. Hande, Mary Lou Keohan, Brian L. Samuels, Scott M. Schuetze, Claudia Lebedinsky, Yusri Elsayed, Miguel Izquierdo, Javier Gómez‐Román, Youn C. Park, Axel Le Cesne - Journal of Clinical Oncology 2009 被引用: 536

  8. R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study

    著者: Alberto S. Pappo, Shreyaskumar Patel, John Crowley, Denise K. Reinke, Klaus-Peter Kuenkele, Sant P. Chawla, Guy C. Toner, Robert G. Maki, Paul A. Meyers, Rashmi Chugh, Kristen N. Ganjoo, Scott M. Schuetze, Heribert Juergens, Michael Leahy, Birgit Geoerger, Robert S. Benjamin, Lee J. Helman, Laurence H. Baker - Journal of Clinical Oncology 2011 被引用: 321

  9. Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

    著者: Charles D. Blanke, Cathryn Rankin, George D. Demetri, Christopher W. Ryan, Margaret von Mehren, Robert S. Benjamin, A. Kevin Raymond, Vivien Bramwell, Laurence H. Baker, Robert G. Maki, Michael Tanaka, J. Randolph Hecht, Michael C. Heinrich, Christopher D.�M. Fletcher, John J. Crowley, Ernest C. Borden - Journal of Clinical Oncology 2008 被引用: 1,077

  10. Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model

    著者: Rashmi Chugh, J. Kyle Wathen, Robert G. Maki, Robert S. Benjamin, Shreyaskumar Patel, Paul A. Myers, Dennis A. Priebat, Denise K. Reinke, Dafydd G. Thomas, Mary Lou Keohan, Brian L. Samuels, Laurence H. Baker - Journal of Clinical Oncology 2009 被引用: 234

  11. Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor

    著者: Scott M. Schuetze, Vanessa Bolejack, Edwin Choy, Kristen N. Ganjoo, Arthur P. Staddon, Warren Chow, Hussein A. Tawbi, Brian L. Samuels, Shreyaskumar Patel, Margaret von Mehren, Gina Z. D’Amato, Kirsten Leu, David M. Loeb, Charles Forscher, Mohammed Milhem, Daniel A. Rushing, David R. Lucas, Rashmi Chugh, Denise K. Reinke, Laurence H. Baker - Cancer 2016 被引用: 132

  12. SARC009: Phase 2 study of dasatinib in patients with previously treated, high‐grade, advanced sarcoma

    著者: Scott M. Schuetze, J. Kyle Wathen, David R. Lucas, Edwin Choy, Brian L. Samuels, Arthur P. Staddon, Kristen N. Ganjoo, Margaret von Mehren, Warren Chow, David M. Loeb, Hussein A. Tawbi, Daniel A. Rushing, Shreyaskumar Patel, Dafydd G. Thomas, Rashmi Chugh, Denise K. Reinke, Laurence H. Baker - Cancer 2015 被引用: 108

  13. Efficacy of Imatinib in Aggressive Fibromatosis: Results of a Phase II Multicenter Sarcoma Alliance for Research through Collaboration (SARC) Trial

    著者: Rashmi Chugh, J. Kyle Wathen, Shreyaskumar Patel, Robert G. Maki, Paul A. Meyers, Scott M. Schuetze, Dennis A. Priebat, Dafydd G. Thomas, Jon A. Jacobson, Brian L. Samuels, Robert S. Benjamin, Laurence H. Baker - Clinical Cancer Research 2010 被引用: 237

  14. Phase II Study of the Mammalian Target of Rapamycin Inhibitor Ridaforolimus in Patients With Advanced Bone and Soft Tissue Sarcomas

    著者: Sant P. Chawla, Arthur P. Staddon, Laurence H. Baker, Scott M. Schuetze, Anthony W. Tolcher, Gina Z. D’Amato, Jean‐Yves Blay, Monica Mita, Kamalesh K. Sankhala, Lori Berk, Victor M. Rivera, Tim Clackson, John W. Loewy, Frank G. Haluska, George D. Demetri - Journal of Clinical Oncology 2011 被引用: 247

  15. The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma

    著者: Hemant K. Bid, Doris A. Phelps, Linlin Xaio, Denis C. Guttridge, Jiayuh Lin, Cheryl A. London, Laurence H. Baker, Xiaokui Mo, Peter J. Houghton - Molecular Cancer Therapeutics 2016 被引用: 90

  16. Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas

    著者: Inga‐Marie Schaefer, Meijun Z. Lundberg, Elizabeth G. Demicco, Joanna Przybył, Magdalena Matusiak, Frédéric Chibon, Davis R. Ingram, Jason L. Hornick, Wei‐Lien Wang, Sebastian Bauer, Laurence H. Baker, Alexander J. Lazar, Matt van de Rijn, Adrián Mariño‐Enríquez, Jonathan A. Fletcher - Cancer 2021 被引用: 35

  17. Chordoma: The Nonsarcoma Primary Bone Tumor

    著者: Rashmi Chugh, Hussein Tawbi, David R. Lucas, J. Sybil Biermann, Scott M. Schuetze, Laurence H. Baker - The Oncologist 2007 被引用: 394

  18. 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial

    著者: E. Robert Greenberg, Garnet L. Anderson, Douglas R. Morgan, Javier Torres, William D. Chey, Luis Eduardo Bravo, Ricardo L. Domínguez, Catterina Ferreccio, Rolando Herrero, Eduardo Lazcano‐Ponce, María Mercedes Meza‐Montenegro, Rodolfo Peña, Edgar M. Peña-Galo, Eduardo Salazar-Martínez, Pelayo Correa, M. Elena Martinez, Manuel Valdivieso, Gary E. Goodman, John J. Crowley, Laurence H. Baker - The Lancet 2011 被引用: 255

  19. Adjuvant therapy for high‐grade, uterus‐limited leiomyosarcoma

    著者: Martee L. Hensley, J. Kyle Wathen, Robert G. Maki, Dejka M. Araujo, Gregory P. Sutton, Dennis A. Priebat, Suzanne George, Robert A. Soslow, Laurence H. Baker - Cancer 2013 被引用: 171

  20. Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results

    著者: Michael C. Heinrich, Cathryn Rankin, Charles D. Blanke, George D. Demetri, Ernest C. Borden, Christopher W. Ryan, Margaret von Mehren, Martin E. Blackstein, Dennis A. Priebat, William D. Tap, Robert G. Maki, Christopher L. Corless, Jonathan A. Fletcher, Kouros Owzar, John J. Crowley, Robert S. Benjamin, Laurence H. Baker - JAMA Oncology 2017 被引用: 126

  21. When Progressive Disease Does Not Mean Treatment Failure: Reconsidering the Criteria for Progression

    著者: Geoffrey R. Oxnard, Michael J. Morris, F. Stephen Hodi, Laurence H. Baker, Mark G. Kris, Alan P. Venook, Lawrence H. Schwartz - JNCI Journal of the National Cancer Institute 2012 被引用: 124

  22. Cutaneous angiosarcoma of the scalp

    著者: Timothy M. Pawlik, Augusto F. G. Paulino, Cornelius J. McGinn, Laurence H. Baker, Deborah S. Cohen, Jeffery S. Morris, Riley S. Rees, Vernon K. Sondak - Cancer 2003 被引用: 342

  23. Laboratory and Clinical Evidence of Synergistic Cytotoxicity of Sequential Treament With Gemcitabine Followed by Docetaxel in the Treatment of Sarcoma

    著者: Kirsten Leu, Leo J. Ostruszka, Donna S. Shewach, Mark M. Zalupski, Vernon K. Sondak, J. Sybil Biermann, Julia Shin-Jung Lee, Carol Couwlier, Krisinda Palazzolo, Laurence H. Baker - Journal of Clinical Oncology 2004 被引用: 245

  24. Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy

    著者: Lawrence Leichman, Norman D. Nigro, Vainutis K. Vaitkevicius, Basil Considine, T Buroker, G. Bradley, H. Gunter Seydel, Steven Olchowski, Glenn Cummings, Cynthia G. Leichman, Laurence H. Baker - The American Journal of Medicine 1985 被引用: 219